Impact Biomedical Inc. (IBO): Cost of Revenue

Annual figures by period end, from SEC filings.

$424.0K

Year ended 2025-12-31

Period ended	Cost of Revenue	Change YoY	Source filing
2025-12-31	$424.0K	n/a	2026-03-11, From 2025-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
Impact Biomedical Inc. (IBO)	2025-12-31	$424.0K	n/a
Jupiter Neurosciences, Inc. (JUNS)	2025-12-31	$4.2K	n/a
HCW Biologics Inc. (HCWB)	2025-12-31	$43.4K	-97.3%
Bioadaptives, Inc. (BDPT)	2025-12-31	$5.8K	-33.1%
PRF Technologies Ltd. (PRFX)	2025-12-31	$70.0K	n/a
Silo Pharma, Inc. (SILO)	2025-12-31	$44.3K	+658.7%
BullFrog AI Holdings, Inc. (BFRG)	2025-12-31	$94.8K	n/a
Aspire-Lakewood Holdings, Inc. (ASBP)	2025-12-31	$6.3K	n/a
Clene Inc. (CLNN)	2025-12-31	$43.0K	-38.6%

Compare IBO, JUNS, HCWB, BDPT side by side · Screen every company in Pharmaceutical Preparations ↗